Literature DB >> 15322209

C5a initiates the inflammatory cascade in immune complex peritonitis.

Jeanne Godau1, Tanja Heller, Heiko Hawlisch, Matthew Trappe, Elaine Howells, Jennifer Best, Jörg Zwirner, J Sjef Verbeek, P Mark Hogarth, Craig Gerard, Nico Van Rooijen, Andreas Klos, J Engelbert Gessner, Jörg Köhl.   

Abstract

Immune complex (IC)-induced inflammation is integral to the pathogenesis of several autoimmune diseases. ICs activate the complement system and interact with IgG FcgammaR. In this study, we demonstrate that activation of the complement system, specifically generation of C5a, initiates the neutrophilic inflammation in IC peritonitis. We show that ablation of C5a receptor signaling abrogates neutrophil recruitment in wild-type mice and prevents the enhancement of neutrophil migration seen in FcgammaRIIB(-/-) mice, suggesting that C5aR signaling is the crucial initial event upstream of FcgammaR signaling. We also provide evidence that C5a initiates the inflammatory cascade both directly, through C5aR-mediated effector functions on infiltrating and resident peritoneal cells, and indirectly, through shifting the balance between activating and inhibitory FcgammaRs on resident cells toward an inflammatory phenotype. We conclude that complement activation and C5a generation are prerequisites for IC-induced inflammation through activating FcgammaR, which amplifies complement-induced inflammation in autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322209     DOI: 10.4049/jimmunol.173.5.3437

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  A bone to pick with Fc gamma receptors.

Authors:  Christian M Karsten; Jörg Köhl
Journal:  Ann Transl Med       Date:  2015-09

Review 2.  The role of complement in danger sensing and transmission.

Authors:  Jörg Köhl
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

4.  Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release.

Authors:  Federica Laudisi; Roberto Spreafico; Maximilien Evrard; Timothy R Hughes; Barbara Mandriani; Matheswaran Kandasamy; B Paul Morgan; Baalasubramanian Sivasankar; Alessandra Mortellaro
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

5.  Alternative complement pathway in schizophrenia.

Authors:  Anna Boyajyan; Aren Khoyetsyan; Andranik Chavushyan
Journal:  Neurochem Res       Date:  2010-01-26       Impact factor: 3.996

6.  Complement-dependent modulation of antitumor immunity following radiation therapy.

Authors:  Michelle Elvington; Melissa Scheiber; Xiaofeng Yang; Katherine Lyons; Dustin Jacqmin; Casey Wadsworth; David Marshall; Kenneth Vanek; Stephen Tomlinson
Journal:  Cell Rep       Date:  2014-07-24       Impact factor: 9.423

Review 7.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

8.  A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA.

Authors:  Gaurav Mehta; Robert I Scheinman; V Michael Holers; Nirmal K Banda
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

Review 9.  B cells and their mediators as targets for therapy in solid tumors.

Authors:  Andrew J Gunderson; Lisa M Coussens
Journal:  Exp Cell Res       Date:  2013-03-13       Impact factor: 3.905

10.  Functional roles for C5a receptors in sepsis.

Authors:  Daniel Rittirsch; Michael A Flierl; Brian A Nadeau; Danielle E Day; Markus Huber-Lang; Charles R Mackay; Firas S Zetoune; Norma P Gerard; Katherine Cianflone; Jörg Köhl; Craig Gerard; J Vidya Sarma; Peter A Ward
Journal:  Nat Med       Date:  2008-05-04       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.